Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stalevo for Sleep Disorders in Parkinson's Disease
NCT02452606Unknown
- Sponsor
- Asan Medical Center
- Start
- Mar 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of levodopa in Parkinson's disease (PD) and sleep disorder, sponsored by Asan Medical Center. Primary endpoint: Correlation of genetic variants of central circadian clock and narcolepsy genes with Stalevo treatment effect at 2 years. Status: unknown.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)sleep disorder
Beyond the preview
Go deeper on NCT02452606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02452606.